Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.

Abstract

Almost universal engraftment can be induced with a combination of intravenous donor-specific transfusion at transplantation plus inhibition of CD28 activation by CTLA4Ig 48 hours after transplantation-a regimen which could have clinical application.